Login to Your Account

Clinic Roundup

Thursday, June 13, 2013
• Biota Pharmaceuticals Inc., of Alpharetta, Ga., began dosing in a Phase II trial of laninamir octanoate, for influenza A or B infection.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription